Form 8-K Eterna Therapeutics Inc. For: Mar 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Eterna Therapeutics (ERNA) Receives Nasdaq Non-compliance Notice
March 22, 2024 4:39 PM EDTOn March 19, 2024, Eterna Therapeutics (NASDAQ: ERNA) received a notice (the Notice) from the Listing Qualifications Staff (Staff) of The Nasdaq Stock Market LLC (Nasdaq) stating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1) because the Company reported stockholders equity of less than $2.5 million as of December 31, 2024. The... More
